HPV 9G DNAChip: Based on the 9G DNAChip technology

Journal of Virological Methods

Volumn 183, Issue 2, 2012, Pages 132-138

  Song, Keum Soo ^b   Nimse, Satish Balasaheb ^a   An, Heejung ^c   Kim, Junghoon ^b   Nguyen, Van Thuan ^a   Ta, Van Thao ^a   Kim, Taisun ^a  

^a Hallym University   (South Korea)

^b Biometrix Technology Inc   (South Korea)

^c CHA University   (South Korea)

Author keywords

Cervical cancer; Cervical neoplasia; Genotype; HPV; HPV 9G DNAChip

Indexed keywords

ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA EXTRACTION; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAILLOMAVIRUS 9G DNA CHIP; HUMAN TISSUE; HYBRIDIZATION; LIMIT OF DETECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHELF LIFE; SIGNAL TO BACKGROUND RATIO; TARGET SPECIFIC HYBRIDIZATION; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; LIMIT OF DETECTION; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR TYPING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA; SIGNAL-TO-NOISE RATIO;

HUMAN PAPILLOMAVIRUS;

EID: 84862155198     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.04.003     Document Type: Article

References (20)

1. Bosch F.X., de Sanjose S. Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. Journal of the National Cancer Institute Monographs 2003, 31:3-13.
2. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology 2002, 55:244-265.
3. Choi Y.-D., Jung W.-W., Nam J.-H., Choi H.-S., Park C.-S. Detection of HPV genotypes in cervical lesions by the HPV DNA chip and sequencing. Gynecologic Oncology 2007, 98:369-375.
4. Choi J., Kim C., Park H. Peptide nucleic acid-based array for detecting and genotyping human papillomaviruses. Journal of Clinical Microbiology 2009, 47:1785-1790.
5. de Villiers E.-M., Fauquet C., Broker T.R., Bernard H.-U., Hausen H.Z. Classification of papillomaviruses. Virology 2004, 324:17-27.
6. Ferlay J., Bray F., Pisani P., Parkin D.M. Globocan 2000: Cancer Incidence, Mortalityand Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5 2001, IARC Press, Lyons, France.
7. Haws A.L.F., He Q., Rady P.L., Zhang L., Grady J., Hughes T.K., Stisser K., Konig R., Tyring S.K. Nested PCR with the PGMY09/11 and GP5+/6+ primer sets improves detection of HPV DNA in cervical samples. Journal of Virological Methods 2004, 122:87-93.
8. Husman R., Walboomers J.M.M., van den Brule A.J.C., Meijer C.J.L.M., Snijders P.J.F. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. The Journal of General Virology 1995, 76:1057-1062.
9. Hwang T.S., Jeong J.K., Park M., Han H.S., Choi H.K., Park T.S. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecologic Oncology 2003, 90:51-56.
10. Kjaer S.K., van den Brule A.J.C., Bock J.E., Poll P.A., Engholm G., Sherman M.E., Walbooomers J.M.M., Meijer C.J.L.M. Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia. International Journal of Cancer 1996, 65:601-606.
11. Kjaer S., Høgdall E., Frederiksen K., Munk C., van den Brule A., Svare E., Meijer C., Lorincz A., Iftner T. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res. 2006, 66:10630-10636.
12. Koshiol J., Lindsay L., Pimenta J.M., Poole C., Jenkins D., Smith J.S. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and metaanalysis. American Journal of Epidemiology 2008, 168:123-137.
13. Meijer C.J., Snijders P.J., Castle P.E. Clinical utility of HPV genotyping. Gynecologic Oncology 2006, 103:12-17.
14. Munoz N., Bosch F.X., de Sanjose S., Tafur L., Izarzugaza I., Gili M., Viladiu P., Navarro C., Martos C., Ascunce N., Gonzalez L.C., Kaldor J.M., Guerrero E., Lorincz A., Santamaria M., Ruiz P.A.D., Aristizabal N., Shah K. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. International Journal of Cancer 1995, 52:743-749.
15. Nimse S.B., Song K., Kim J., Kim J., Nguyen V., Ta V., Kim T. A generalized probe selection method for DNAChips. Chemical Communications 2011, 47:12444-12446.
16. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., Scott D.R., Sherman M.E., Kumaran R.J., Wacholder S., Stanton C.K., Manos M.M. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute 1993, 85:958-964.
17. Song K., Nimse S.B., Kim J., Kim J., Nguyen V., Ta V., Kim T. 9G DNAChip: Microarray based on the multiple interactions of 9 consecutive guanines. Chemical Communications 2011, 47:7101-7103.
18. Song K., Nimse S.B., Kim J., Kim J., Nguyen V., Ta V., Kim T. 9G DNAChip: A Platform for the Efficient Detection of the Proteins. Chemical Communications 2011, 47:7616-7618.
19. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J.F., Peto J., Meijer C.J.L.M., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 1999, 189:12-19.
20. Wong C.W., Heng C.L.W., Yee L.W., Soh S.W.L., Kartasasmita C.B., Simoes E.A.F., Hibberd M.L., Sung W.K., Miller L.D. Optimization and clinical validation of a pathogen detection microarry. Genome Biology 2007, 8:R93.